Risk of amyloid-related imaging abnormalities associated with anticoagulant therapy in patients with Alzheimer's disease treated with anti-amyloid monoclonal antibodies: a systematic review and meta-analysis
J Neurol Neurosurg Psychiatry. 2026 Mar 13;97(4):367-368.
doi: 10.1136/jnnp-2025-337386.
1 Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany e.schlemm@uke.de m.woo@uke.de.
2 Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, McConnell Brain Imaging Centre (BIC), Montreal Neurological Institute-Hospital, Montreal, Quebec, Canada.
3 Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
4 The University of Texas Southwestern Medical Center Peter O'Donnell Jr Brain Institute, Dallas, Texas, USA.
5 Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, McConnell Brain Imaging Centre (BIC), Montreal Neurological Institute-Hospital, Montreal, Quebec, Canada e.schlemm@uke.de m.woo@uke.de.
6 Translational Neurodegeneration Laboratory, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
7 Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.